FDA Warning on Xylazine: Mitigating Human Risk | by: Sumeet Singh, Founder & Chairman | Article Posted: November 6, 2023 | The U.S. Food and Drug Administration (FDA) has issued a warning regarding mitigating risks from human Xylazine exposure. FDA has not...
Pharma Solutions' NavigateSOM Software! On April 24th NavigateSOM was published in the Trademark Official Gazette! Pharma Solutions launched a...
Two Years In: a Look Back (and Forward!) The Beginnings Two years ago, Pharma Solutions was born as a value-add for OpenRX, a self-proclaimed...
A Look Back: One Year into OptumRX’s VAWD Requirement Last month OptumRX demonstrated their continued commitment to their VAWD requirement in a...
Pharma Solutions Completes On-Site Audit for Real Value Products Pharma Solutions was engaged by Real Value Products for an on-site audit of their...
Why Sumeet Singh, President of Pharma Solutions, Believes Amazon Can and Will Jump Into the Pharmaceutical and Medical Device Industries America and...
Pharma Solutions Joins the Healthcare Distribution Alliance (HDA) Pharma Solutions is proud to announce that the company has joined the Healthcare...
